trending Market Intelligence /marketintelligence/en/news-insights/trending/n0yuVKiroLcrJPYFiIWaRA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Assembly Biosciences raises $143.7M via common stock, warrants offering


Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection


Banking Essentials Newsletter - February Edition


Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Assembly Biosciences raises $143.7M via common stock, warrants offering

Assembly Biosciences Inc. raised about $143.7 million in gross proceeds from an offering of common stock and warrants.

The Carmel, Ind.-based biotech sold 6,287,878 common shares at $16.50 apiece in the offering, including full exercise by underwriters of their option to purchase an additional 1,136,363 shares.

Moreover, Assembly Biosciences also sold prefunded warrants to buy up to 2,424,242 common shares to a certain existing investor at about $16.50 per warrant.

The company plans to use the net proceeds from the offering to fund clinical trials, nonclinical studies, research and development, and for general corporate purposes.

Jefferies LLC, SVB Leerink LLC and William Blair & Co. LLC were the joint book-running managers, while Mizuho Securities USA LLC and Robert W. Baird & Co. Inc. were the co-managers for the offering.